Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 125.91 | 35.17 |
| PEG Ratio (TTM) | 0.34 | 2.24 |
| P/S Ratio (TTM) | 5.22 | 3.94 |
| P/B Ratio (TTM) | 3.00 | 7.16 |
| P/FCF Ratio (TTM) | 13.29 | 22.50 |
| Price to 5YR AVG Earnings Ratio | N/A | 35.58 |
| Price to 5YR AVG FCF Ratio | N/A | 27.73 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.62% | 6.17% |
| ROE (TTM) | 2.49% | 21.27% |
| Net Profit Margin (TTM) | 4.23% | 10.39% |
| ROIC 5YR AVG | N/A | 19.18% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -100.21% | -43.28% | N/A |
| Revenue | 9.28% | 45.11% | N/A |
| Net Income | -103.50% | -49.22% | N/A |
| Cash Flow | 250.71% | -100.09% | N/A |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.33 | 1.74 |
| Quick Ratio (TTM) | 2.33 | 1.74 |
| D/E Ratio (TTM) | N/A | 1.09 |
| Interest Coverage (TTM) | -21.44 | 28.66 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 4.50 | 5.33 |
| LTL to 5YR AVG FCF | N/A | 3.71 |
| Shares Outstanding Growth 5YR AVG | N/A | 2.43% |